FOSL1 and breast carcinoma: However, a clear shift from nuclear to a simultaneous nuclear/cytoplasmic localization of Fra-1 was noticed in ∼90% of breast carcinomas examined which led them to conclude that a non-transcriptional function of Fra-1 remained to be demonstrated [31].